CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,387,000 | +1524.1% | 588,213 | +679.1% | 0.02% | +1400.0% |
| Q2 2022 | $1,871,000 | +19.6% | 75,500 | +21.0% | 0.00% | 0.0% |
| Q1 2022 | $1,564,000 | -31.0% | 62,400 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $2,268,000 | +109.6% | 62,300 | -1.6% | 0.00% | – |
| Q3 2021 | $1,082,000 | +14.1% | 63,300 | -10.6% | 0.00% | – |
| Q2 2021 | $948,000 | -81.0% | 70,800 | -27.3% | 0.00% | -100.0% |
| Q1 2021 | $4,988,000 | -16.7% | 97,341 | +0.6% | 0.00% | -33.3% |
| Q4 2020 | $5,990,000 | +6.1% | 96,741 | -6.1% | 0.00% | 0.0% |
| Q3 2020 | $5,647,000 | -13.6% | 103,041 | -9.3% | 0.00% | -25.0% |
| Q2 2020 | $6,535,000 | +58.4% | 113,580 | +10.6% | 0.00% | +33.3% |
| Q1 2020 | $4,126,000 | +18.4% | 102,680 | +16.5% | 0.00% | +50.0% |
| Q4 2019 | $3,486,000 | +767.2% | 88,150 | +48.7% | 0.00% | – |
| Q3 2019 | $402,000 | -27.0% | 59,300 | 0.0% | 0.00% | – |
| Q2 2019 | $551,000 | -14.7% | 59,300 | +27.5% | 0.00% | – |
| Q1 2019 | $646,000 | +26.9% | 46,500 | -0.4% | 0.00% | – |
| Q4 2018 | $509,000 | -13.7% | 46,700 | 0.0% | 0.00% | – |
| Q3 2018 | $590,000 | -4.1% | 46,700 | 0.0% | 0.00% | – |
| Q2 2018 | $615,000 | +12.8% | 46,700 | +16.5% | 0.00% | – |
| Q1 2018 | $545,000 | +144.4% | 40,100 | +6.9% | 0.00% | – |
| Q4 2017 | $223,000 | -19.8% | 37,500 | 0.0% | 0.00% | – |
| Q3 2017 | $278,000 | -81.4% | 37,500 | -76.5% | 0.00% | -100.0% |
| Q2 2017 | $1,495,000 | +14.0% | 159,687 | -11.3% | 0.00% | 0.0% |
| Q1 2017 | $1,311,000 | -56.7% | 180,087 | -56.0% | 0.00% | -66.7% |
| Q4 2016 | $3,031,000 | +1486.9% | 409,640 | +1192.2% | 0.00% | – |
| Q3 2016 | $191,000 | +34.5% | 31,700 | 0.0% | 0.00% | – |
| Q2 2016 | $142,000 | +343.8% | 31,700 | +637.2% | 0.00% | – |
| Q1 2015 | $32,000 | +18.5% | 4,300 | +10.3% | 0.00% | – |
| Q4 2014 | $27,000 | +28.6% | 3,900 | -17.0% | 0.00% | – |
| Q3 2014 | $21,000 | -22.2% | 4,700 | 0.0% | 0.00% | – |
| Q2 2014 | $27,000 | -44.9% | 4,700 | -36.5% | 0.00% | – |
| Q1 2014 | $49,000 | -46.2% | 7,400 | -53.1% | 0.00% | – |
| Q4 2013 | $91,000 | -35.0% | 15,782 | -37.4% | 0.00% | – |
| Q3 2013 | $140,000 | -71.9% | 25,217 | -28.5% | 0.00% | -100.0% |
| Q2 2013 | $499,000 | – | 35,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |